# UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients

> **NCT00111748** · PHASE3 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 180 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade, Thalidomide, Dexamethasone

## Key facts

- **NCT ID:** NCT00111748
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2015-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111748, "UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00111748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*